The FDA Just Approved Daxxify, an Injectable Neurotoxin That Lasts Months Longer Than Botox

After a lengthy approval process, the U.S. Food and Drug Administration (FDA) has finally approved Revance’s highly anticipated daxibotulinumtoxinA, now called Daxxify.